Enovis Corp (ENOV)

Apr 03, 2025

Canaccord maintains Buy rating and $75 target for Enovis stock - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Enovis Receives Buy Rating Amidst Strategic Leadership Change and Strong Financial Projections - TipRanks

Apr 03, 2025

Apr 03, 2025

Enovis’s Promising Future: Buy Rating Backed by Strategic Leadership and Positive Financial Outlook - TipRanks

Apr 03, 2025

Apr 03, 2025

Enovis names Damien McDonald as new CEO starting May 12 By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 02, 2025

Enovis Names Damien McDonald as New CEO to Drive Next Growth Chapter - MSN

Apr 02, 2025

Apr 02, 2025

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Enovis (ENOV) and Auckland International Airport Limited (OtherACKDF) - The Globe and Mail

Apr 02, 2025

Apr 02, 2025

Enovis names Damien McDonald as CEO, succeeding Matt Trerotola - TipRanks

Apr 02, 2025

Apr 02, 2025

Strategic Leadership and Financial Stability Drive Buy Rating for Enovis - TipRanks

Apr 02, 2025

Apr 02, 2025

Enovis (ENOV) Appoints New CEO and Confirms Revenue Forecast - GuruFocus

Apr 02, 2025

Apr 02, 2025

Enovis Corporation Reiterats Earnings Guidance for the First Quarter of 2025 - MarketScreener

Apr 02, 2025

Apr 02, 2025

Former LivaNova CEO to take corner office at Enovis - MassDevice

Apr 02, 2025

Apr 02, 2025

Enovis names McDonald as CEO - MSN

Apr 02, 2025

Apr 02, 2025

Enovis Names Damien McDonald as Chief Executive; Reaffirms Q1 Revenue Guidance - MarketScreener

Apr 02, 2025

Apr 02, 2025

Enovis names Damien McDonald as new CEO starting May 12 - Investing.com India

Apr 02, 2025

Apr 02, 2025

Enovis Appoints Damien McDonald as New CEO - TipRanks

Apr 02, 2025

Apr 02, 2025

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer - The Manila Times

Apr 02, 2025

Apr 02, 2025

Enovis Announces Appointment Of Damien Mcdonald As Chief Executive Officer - MarketScreener

Apr 02, 2025

Apr 02, 2025

Medical Device Expert Takes Helm at Enovis: Former LivaNova CEO to Drive Growth - Stock Titan

Apr 02, 2025

Apr 01, 2025

Enovis Corporation (NYSE:ENOV) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st

Apr 01, 2025

Mar 30, 2025

Enovis Showcases Innovative Foot and Ankle Solutions at ACFAS Conference - MSN

Mar 30, 2025

Mar 26, 2025

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

Enovis, Foundation Surgical and J&J MedTech Named Winners of OMTEC® Awards, Honoring Excellence in Orthopedic Innovation - Ortho Spine News

Mar 25, 2025

Mar 25, 2025

Revolutionary Bunion Surgery System Leads Enovis's Major Product Launch at ACFAS 2025 - Stock Titan

Mar 25, 2025

Mar 24, 2025

Enovis : trade; Publishes 2024 Corporate Social Responsibility Report -March 24, 2025 at 04:41 pm EDT - MarketScreener

Mar 24, 2025

Mar 19, 2025

Enovis Corp (ENOV) Stock Price Up 1.77% on Mar 19 - GuruFocus.com

Mar 19, 2025

Mar 18, 2025

Enovis Plans Leadership Change - The Healthcare Technology Report.

Mar 18, 2025

Mar 14, 2025

Enovis CEO Matthew Trerotola Announces Retirement Plan - TipRanks

Mar 14, 2025

Mar 12, 2025

Positive Outlook for Enovis: Strong Market Position and Strategic Growth Initiatives - TipRanks

Mar 12, 2025

Mar 10, 2025

Diabetic Footwear Market Demand : Identifying Key Growth Opportunities By 2032 | Enovis companies, Pilgrim - EIN News

Mar 10, 2025

Mar 07, 2025

Enovis Corporation Announces Participation in Upcoming Investor Conferences - MSN

Mar 07, 2025

Mar 06, 2025

Enovis Positioned for Growth: Buy Rating Highlights Strategic Execution and Undervaluation - TipRanks

Mar 06, 2025

Mar 05, 2025

Enovis to Participate in Upcoming Investor Conferences - The Manila Times

Mar 05, 2025

Mar 05, 2025

Enovis Leadership Reveals Investor Conference Schedule: Key Dates for Healthcare Investors - StockTitan

Mar 05, 2025

Mar 05, 2025

Enovis Hits Another 52-Week Low. Here’s Why It’s A Contrarian Buy. - Barchart

Mar 05, 2025

Mar 05, 2025

Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy. - TradingView

Mar 05, 2025

Mar 04, 2025

Enovis : rsquo; Louie Vogt on driving recon growth past $1B with M&A, knee breakthroughs, and foot and ankle expansion - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Enovis Corporation Reports Strong Growth Amid Challenges - MSN

Mar 04, 2025

Mar 01, 2025

William Blair Issues Optimistic Outlook for Enovis Earnings - MarketBeat

Mar 01, 2025

Mar 01, 2025

Enovis (NYSE:ENOV) Issues FY 2025 Earnings Guidance - MarketBeat

Mar 01, 2025

Feb 28, 2025

Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates - MSN

Feb 28, 2025

Feb 28, 2025

Enovis Positioned for Growth: Buy Rating Backed by Strong Sales, Product Launches, and Attractive Valuation - TipRanks

Feb 28, 2025

Feb 28, 2025

Enovis (NYSE:ENOV) Reaches New 1-Year Low on Analyst Downgrade - MarketBeat

Feb 28, 2025

Feb 28, 2025

Enovis Reports Strong 2024 Sales Growth Despite Goodwill Impairment Charge - MSN

Feb 28, 2025

Feb 28, 2025

Needham & Company LLC Has Lowered Expectations for Enovis (NYSE:ENOV) Stock Price - MarketBeat

Feb 28, 2025

Feb 28, 2025

Enovis Continues To Languish Despite Decent Financial Results (NYSE:ENOV) - Seeking Alpha

Feb 28, 2025

Feb 28, 2025

Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus.com

Feb 28, 2025

Feb 28, 2025

Diabetic Footwear Market Future Business Opportunities 2025-2032 | Enovis companies, Pilgrim Shoes, Drew Shoe - EIN News

Feb 28, 2025

Feb 27, 2025

Enovis (NYSE:ENOV) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat

Feb 27, 2025

Feb 27, 2025

Enovis Corporation (NYSE:ENOV) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025